Behçet's disease, myelodysplastic syndrome, trisomy 8, gastroenterological involvement - An association

Clinical and Experimental Rheumatology

Volumn 23, Issue 4 SUPPL 38, 2005, Pages

  Eder, Lihi ^a,d   Rozenbaum, Michael ^b,c   Boulman, Nina ^b   Aayubkhanov, Elena ^b   Wolfovitz, Efrat ^b   Zisman, Devi ^a   Rosner, Itzhak ^b  

^a CARMEL MEDICAL CENTER   (Israel)

^b BNAI ZION MEDICAL CENTER   (Israel)

^c Zvulon Clinic   (Israel)

^d Bnai Zion Medical Center ^*

Author keywords

Beh et's disease; Gastrointestinal Beh et's; Myelodysplastic syndrome; Trisomy 8

Indexed keywords

AMPHOTERICIN B; AZITHROMYCIN; C REACTIVE PROTEIN; CEFUROXIME; CHLORAMBUCIL; COLCHICINE; GENTAMICIN; HYDROXYCHLOROQUINE; INFUSION FLUID; MEROPENEM; METHYLPREDNISOLONE; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; PREDNISONE; STEROID; VANCOMYCIN; IMMUNOSUPPRESSIVE AGENT;

ABDOMINAL PAIN; ACUTE LEUKEMIA; ADULT; ANKLE ARTHRITIS; ARTICLE; BEHCET DISEASE; BONE MARROW BIOPSY; CAMPYLOBACTER JEJUNI; CASE REPORT; CAUSE OF DEATH; DETERIORATION; DIARRHEA; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ELECTRONIC MEDICAL RECORD; ERYTHEMA NODOSUM; FECES CULTURE; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; GENITAL ULCER; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; HYPOALBUMINEMIA; HYPOKALEMIA; KNEE ARTHRITIS; LOW DRUG DOSE; MIDDLE AGED; MOUTH ULCER; MULTIPLE ORGAN FAILURE; MYELODYSPLASTIC SYNDROME; NONHUMAN; PANCYTOPENIA; PROTEIN BLOOD LEVEL; REFRACTORY ANEMIA WITH EXCESS BLASTS; TRISOMY 8; CHROMOSOME 8; FATALITY; GASTROINTESTINAL DISEASE; GENETICS; IMMUNE DEFICIENCY; PATHOLOGY; TRISOMY;

BEHCET SYNDROME; CHLORAMBUCIL; CHROMOSOMES, HUMAN, PAIR 8; FATAL OUTCOME; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; MULTIPLE ORGAN FAILURE; MYELODYSPLASTIC SYNDROMES; TRISOMY;

EID: 33644803393     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. SAKANE T, TEKENO M, SUZUKI N, INABA G: Behçet's disease. New England Journal of Medicine 1999; 341: 1284-91.
2. MARSHALL SE: Behçet's disease. Best Pract Res Clin Rheumatol 2004;18:292-311.
3. FRENCH-CONSTANT C, WOLMAN R, JAMES DG: Cyclosporin in Behçet's disease. Lancet 1983;II:454-5.
4. KAWAMOTO S, TERADA H, NIIKURA H, KUMASAKA T, SAIKI S: Hodgkin's disease associated with Behçet's disease. Rinsho Ketsueki 1992; 33: 211-5.
5. ABE T, YACHI A, YABANA T et al.: Gastric non-Hodgkin's lymphoma associated with Behçet's disease. Intern Med 1993; 32: 663-7.
6. KATSURA Y, SUZUKAWA K, KOJIMA H et al.: Cytotoxic T cell lymphoma arising in Behçet's disease. Int J Hematol 2003; 77: 282-5.
7. YAMAMOTO T, TAMURA M, HAMAUZU T et al.: Intestinal Behçet's disease associated with Non-Hodgkin's lymphoma. J Gastroenterol 1997; 32: 241-5.
8. HOUMAN MH, BEN GHORNEL I, MILED M: Intestinal lymphoma associated with Behçet's disease. Ann Med Interne 2001 152: 415-8.
9. INTERNATIONAL STUDY GROUP FOR BEHÇET'S DISEASE: Criteria for diagnosis of Behçet's Disease. Lancet 1990; 335: 1078-80.
10. VOULGARELIS M, GIANNOULI S, RITIS K, TZIOUFAS AG: Myelodysplasia-associated autoimmunity: Clinical and pathophysiologic concepts. Eur J Clin Invest 2004;34:690-700.
11. GIANNOULI S, VOULGARELIS M, ZINTZARAS E, TZIOUFAS G, MOUTSOPOULOS HM: Autoimmune phenomena in myelodysplastic syndromes: A 4-yr prospective study. Rheumatology 2004; 43: 626-32.
12. CASTRO M, CONN DL, SU WP, GARTON JP: Rheumatic manifestations in myelodysplastic syndromes. J Rheumatol 1991; 18: 721-7.
13. AMBERGER C, DENZLINGER C, JANZEN J, MULLER-SCHIMPFLE M, MOHREN M, KOTTER I: Takayasu's arteritis secondary to myelodysplasia as a predictor of poor outcome: Two case reports. Clin Exp Rheum 2004; 22: 346-8.
14. BLANCO R, GONZALEZ-GAY MA, IBANEZ D et al.: Henoch-Schonlein purpura as clinical presentation of a myelodysplastic syndrome. Clin Rheum 1997; 16: 626-8.
15. BLACK KA, ZILKO PJ, DAWKINS RL, ARMSTRONG BK, MASTAGLIA GL: Cancer in connective tissue disease. Arthritis Rheum 1982; 25: 1130-3.
16. BARNES BE, MAWR B: DermatoAyositis and malignancy: a review of the literature. Ann Intern Med 1976; 84: 68-76.
17. CANOSO J, COHEN AS: Malignancy in series of 70 patients with SLE. Arthritis Rheum 1974; 17: 383-8.
18. CENGIZ M, ALTUNDAG MK, ZORLU AF, GULLU IH, OZYAR E, ATAHAN IL: Malignancy in Behçet's disease: A Report of 13 cases and a review of the literature. Clinl Rheumatol 2001; 20: 239-44.
19. OH EJ, YOON JS, PARK YJ, CHO CS, KIM BK: Behçet's disease associated with myelodysplastic syndrome: A case report. J Korean Med Sci 1999; 14: 685-7.
20. NAWATA R, SHINOHARA K, TAKAHASHI T, YAMADA T, KATSUKI K: Refractory anemia with trisomy 8 complicated by Behçet's disease with elevated levels of inflammatory cytokines. Rinsho Ketsueki 1999; 40: 1100-1104.
21. CHYUMA Y, UTSUNOMIYA A, SAITO T, HANADA S, NISHIMATA H, ARIMA T: Hemolytic anemia complicated with Behçet's disease and myelodysplastic syndrome. Rinsho Ketsueki 1992; 33: 333-7.
22. KARUVANNUR S, LIPSTEIN E, ROSNER F: Atypical Behçet's disease in a patient with myelodysplastic syndrome. Mt Sinai J Med 2001; 68: 403-5.
23. YANO K, EGUCHI K, MIGITA K et al.: Behçet's disease complicated with myelodysplastic syndrome report of two cases and review of the literature. Clin Rheumatol 1996; 15: 91-3.
24. OGAWA H, KURODA T, INADA M et al.: Intestinal Behçet's disease associated with myelodysplastic syndrome with chromosomal trisomy 8: A report of two cases and review of the literature. Hepatogastroenterology 2001; 48: 416-20.
25. TANAKA E, NISHINARITA M, UESATO M, KAMATANI N: A case of intestinal Behçet's disease with abnormal ossification complicated by myelodysplastic syndrome, symptoms revealed after the perforation of ileum ulcer. Ryumachi 2000; 40: 711-8.
26. OHNO E, OHTSUKA E, WATANABE K et al.: Behçet's disease associated with myelodysplastic syndromes. Cancer 1997; 79: 262-8.
27. BANGERTER M, GRIESSHAMMER M, V TIRPITZ C et al.: Myelodysplastic syndrome with monosomy 7 after immunosuppressive therapy in Behçet's disease. Scand J of Rheumatol 1999; 28: 117-9.
28. NAKAYAMA S, ISHIKAWA T, YABE H, NAGAI K: Refractory anemia complicated by Behçet's disease. Rinsho Ketsueki 1989; 3 530-4.
29. NESHASHI Y, TORII Y, YAGUCHI M, ITOH Y, OHAYASHIKI K, TOYAMA K: Incomplete Behçet disease in a case of monopathic myelodysplastic syndrome presenting as thrombocytopenia. Rinsho Ketsueki 1988; 29: 1097-102.
30. TAKASHITA N, HORIUCHI T, HATO T, FUJITA S, KOBAYASHI Y: Myelodysplastic syndrome complicated with Behçet's disease. Ehime Igaku 1991; 11: 39-43.
31. YOSHIZAWA Y, HIRAI A, IZAKI S, KITAMURA K: Behçet's disease associated with myelodysplastic disorder. Hifu Rinsyo 1992; 34: 1585-9.
32. KEGEYAMA H. HIDAKA T, KONDO S, TAMARU K: Intestinal Behçet's disease associated with myelodysplastic syndrome. Rinsho Ketsueki 1993; 34: 1288.
33. SHINYA K, KIMURA S, KURODA J et al.: Trisomy 8 involved in myelodysplastic syndrome as a risk factor for intestinal ulcers and thrombosis - Behçet's disease. Leukemia and Lymphoma 2001; 42: 115-21.
34. MOLINA M, AGUAYO JL, ORTEGA G, DE PACO M, CUESTA F, AGUADO MD: Non-specific digestive ulcers and Behçet's disease. Annales de Medicina Interna 1992; 9: 237-38.
35. YAMATO K: Successful cord blood stem cell transfusion for myelodysplastic syndrome with Behçet's disease. Int J Hematol 2003; 77: 82-5.
36. TOMONARI A, TOJO A, TAKAHASHI T et al.: Resolution of Behçet's disease after HLA-mismatched cord blood transplantation for myelodysplastic syndrome. Ann Hematol 2004; 83: 464-6.
37. HASEGAWA H, IWAMASA K, HATTA N, FUJITA S: Behçet's disease associated with myelodysplastic syndrome with elevated levels of inflammatory cytokines. Modern Rheumatol 2003; 13: 350-5.
38. DELLA ROSSA A, TAVONI A, TOGNETTI C, BOMBARDIERI S: Behçet's disease with gastrointestinal involvement associated with myelodysplasia in a patient with congenital panhypopituitarism. Clin Rheum 1998; 17: 515-7.
39. SOLE F, PRIETO F, BADIA L, WOESSNER S, FLORENSA L, SANS-SABRAFEN J: Cytogenetic studies in 112 cases of untreated myelodysplastic syndromes. Cancer Genetics and Cytogenetics 1992; 64: 12-20.
40. KRAUSE I, MADER R, SULKES J, PAUL M, UZIEL W, ADAWI M, WEINBERGER A: Behçet's disease in Israel: The influence of ethnic origin on disease expression and severity. J Rheumatol 2001; 28: 1033-6.
41. BAYRAKTAR Y, OZASLAN E, VAN THIEL D: Gastrointestinal manifestation of Behçet's disease. J Clin Gastroenterol 2000; 30: 144-54.
42. ASTEN P, BARRETT J, SYMMONS D: Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases. J Rheumatol 1999; 26: 1705-14.
43. MATTESON E, HICKEY A, MAGUIRE L, TILSON H, UROWITZ M: Occurrence of neoplasia in patients with rheumatoid arthritis enrolled in DMARD registry. J Rheumatol 1991; 18: 809-14.
44. PATAPANIAN H, GRAHAM S, SAMBROOK PN et al.: The oncogenicity of chlorambucil in rheumatoid arthritis. Br J Rheumatol 1988; 27: 44-7.
45. GERSON S: Molecular epidemiology of therapy related leukemias. Curr Opin Oncol 1993; 5: 136-44.
46. RYFFEL B: The carcinogenicity of cyclosporin. Toxicology 1992; 73: 1-22.
47. CONOR J, SHELDON S, MCCUNE J: Cytogenetic abnormalities and therapy-ralated myelodysplastic syndromes in rheumatic disease. Arthritis Rheum 1988; 41: 1493-6.
48. LE BEAU MM, ALBAIN KS: Clinical and cytogenetic correlation in 63 patients with therapy-related myelodysplastic syndromes and acute non-lymphocytic leukemia: Further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol 1986; 4: 325-33.